CD19 and acute lymphoblastic leukemia: AB CD19-CAR NK cells were significantly superior at killing Nalm-6 at 10:1 ratio, ALL cells at 10:1 and 5:1 ratios, and CLL cells at 1:1 ratio (Fig. 5a).